Skip to main content
    C

    Canopy Growth Corp (CGC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.74
    +0.02 (+2.91%)

    Market Cap: $321.11M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    26%(10/39)
    Avg Surprise
    -162.18%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.03
    Range$-0.03 - $-0.03
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$-0.030.0%
    7d ago$-0.030.0%
    Current$-0.03
    Revenue Consensus
    $82M
    Range$79M - $83M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.01
    Range$-0.01 - $-0.01
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$-0.010.0%
    7d ago$-0.010.0%
    Current$-0.01
    Revenue Consensus
    $89M
    Range$84M - $93M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$0.00---
    Dec 26EST
    		-$-0.01---
    Sep 26EST
    		-$-0.03---
    Jun 26
    Reported Aug 7
    		$-0.02$-0.04+50.00%Beat+89.5%
    Mar 26
    Reported Jun 15
    		$-0.17$-0.06-183.33%Miss+88.1%
    Dec 25
    Reported Feb 6
    		$-0.14$-0.05-180.00%Miss+86.8%
    Sep 25
    Reported Nov 7
    		$-0.01N/A+90.91%Beat+99.2%
    Jun 25
    Reported Aug 8
    		$-0.19$-0.12-58.33%Miss+87.3%
    Mar 25
    Reported May 30
    		$-1.43$-0.25-472.00%Miss-38.8%
    Dec 24
    Reported Feb 7
    		$-1.06$-0.23-360.87%Miss+51.6%
    Sep 24
    Reported Nov 7
    		$-1.23$-0.32-284.38%Miss+42.5%
    Jun 24
    Reported Aug 9
    		$-1.50$-0.37-305.41%Miss-206.1%
    Mar 24
    Reported May 29
    		$-1.03$-0.45-128.89%Miss+19.5%
    Dec 23
    Reported Feb 9
    		$-2.19$-0.47-365.96%Miss+52.1%
    Sep 23
    Reported Nov 8
    		$-2.14$-1.16-84.48%Miss+35.0%
    Jun 23
    Reported Aug 9
    		$-0.49N/A+75.50%Beat+94.4%
    Mar 23
    Reported Jun 22
    		$-1.28$-0.20-540.00%Miss+12.3%
    Dec 22
    Reported Feb 9
    		$-4.57$-2.26-102.21%Miss-183.9%
    Sep 22
    Reported Nov 9
    		$-3.29$-2.60-26.54%Miss-2890.9%
    Jun 22
    Reported Aug 5
    		$-8.71$-2.81-209.96%Miss-172.0%
    Mar 22
    Reported May 27
    		$-1.46$-0.32-356.25%Miss+21.1%
    Dec 21
    Reported Feb 9
    		$-1.61$-3.17+49.21%Beat+87.5%
    Sep 21
    Reported Nov 5
    		$-0.11N/A+94.12%Beat-103.6%
    Jun 21
    Reported Aug 6
    		$12.10$-2.88+520.14%Beat+570.8%
    Mar 21
    Reported Jun 1
    		$-1.85$-0.26-611.54%Miss-19.4%
    Dec 20
    Reported Feb 9
    		$-12.86$-3.32-287.35%Miss-234.9%
    Sep 20
    Reported Nov 9
    		$3.04$-3.58+184.92%Beat+127.4%
    Jun 20
    Reported Aug 10
    		$-2.57$-4.94+47.98%Beat-756.7%
    Mar 20
    Reported May 29
    		$-1.55$-0.59-162.71%Miss+85.8%
    Dec 19
    Reported Feb 14
    		$-3.84$-4.66+17.60%Beat-6.1%
    Sep 19
    Reported Nov 14
    		$-11.08$-3.61-206.93%Miss+15.3%
    Jun 19
    Reported Aug 14
    		$-0.30$-0.51+41.18%Beat+25.0%
    Mar 19
    Reported Jun 20
    		$-10.91$-2.83-285.51%Miss-260.1%
    Dec 18
    Reported Feb 14
    		$-3.62$-2.14-69.16%Miss-135.1%
    Sep 18
    Reported Nov 14
    		$-13.08$-1.00-1208.00%Miss-990.0%
    Jun 18
    Reported Aug 14
    		$-0.40$-0.13-207.69%Miss+53.5%
    Mar 18
    Reported Jun 27
    		$-3.03$-0.75-304.00%Miss-2064.3%
    Dec 17
    Reported Feb 14
    		$-1.54$-0.70-120.00%Miss-258.1%
    Sep 17
    Reported Nov 14
    		$-1.20$-0.50-140.00%Miss-
    Jun 17
    Reported Aug 14
    		$-0.86$-0.65-32.31%Miss-
    Mar 17
    Reported Jun 27
    		$-0.14$-0.05-180.00%Miss-
    Dec 16
    Reported Feb 14
    		$-0.43$-0.35-22.86%Miss-

    Key Metrics

    Valuation
    P/E Ratio-2.16EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-79.20%Operating Margin-21.70%
    ROE-39.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio3.04xQuick Ratio2.39x
    Trading Statistics
    Beta2.37Avg Volume2.53M
    52-Week High$2.3852-Week Low$0.71

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.82
    SMA 20$0.87
    SMA 50$0.94
    SMA 200$1.03
    EMA 10$0.80
    EMA 20$0.85
    EMA 50$0.91
    EMA 200$1.02

    MACD

    Line: -0.05Signal: -0.04Hist: -0.02

    ADX

    ADX: 37.1+DI: 4.9-DI: 36.9

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down100.0
    PSAR$0.86

    Bollinger Bands

    Upper Band$1.02
    Lower Band$0.72
    %B Position3424%(Upper)
    Band Width0.04

    RSI (14-Day)

    Oversold
    24.5

    Momentum Oscillators

    Stoch %K9.8
    Stoch %D8.3
    Williams %R-83.0
    ROC (10d)-16.6%
    Momentum-0.15
    CCI (20d)-177.6
    MFI (14d)9.1

    Volatility Measures

    ATR (14d)$0.04(5.6%)
    StdDev (20d)0.07
    Hist Vol46.8%(High)

    Volume Flow

    VWAP$0.72
    OBV-124.2M
    AD Line-976.1M
    CMF (20d)-0.229

    Volume Metrics

    Avg Vol (20d)2.6M
    Vol Ratio1.0x
    VWMA (20d)$0.85

    Pivot Points

    R3$0.80
    R2$0.78
    R1$0.75
    Pivot Point$0.73
    S1$0.70
    S2$0.68
    S3$0.65

    Advanced Oscillators

    TSI-44.27
    Ultimate Osc36.6
    KST-143.42

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$13.30M$65.92M$59.60M$65.16M$17.06M$59.89M$54.74M$55.38M$50.94M$59.46M$51.42M$57.63M
    Cost of Revenue$7.99M$50.27M$43.87M$51.92M$11.50M$43.16M$38.58M$38.55M$40.30M$38.08M$34.11M$47.23M
    Gross Profit$5.30M$15.65M$15.73M$13.24M$5.57M$16.73M$16.16M$16.83M$10.65M$21.38M$17.31M$10.40M
    Operating Expenses$73.21M$34.87M$27.86M$29.85M$15.22M$33.28M$50.17M$38.10M$87.40M$67.07M$22.48M$51.70M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$28.21M$32.41M$26.06M$27.98M$23.23M$28.80M$30.89M$35.05M$38.21M$41.23M$42.56M$47.43M
    Operating Income$-67,901,667$-19,216,744$-12,130,394$-16,610,866$-9,649,355$-16,543,056$-34,004,145$-21,271,558$-76,750,414$-45,687,017$-5,176,949$-41,302,902
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$43.80M$26.19M$0$16.11M$72.02M$67.89M$63.14M$68.61M$16.56M$129.55M$94.82M$0
    Income Before Tax$-111,703,499$-45,404,755$-1,023,192$-32,723,935$-81,670,137$-84,430,556$-97,141,588$-89,883,806$-93,315,230$-175,240,873$-99,993,351$-6,462,364
    Income Tax Expense$-619,208$268,378$153,658$213,656$-3,150$219,444$223,522$4.53M$-1,077,649$-815,785$9.47M$1.53M
    Net Income$-111,084,290$-45,673,133$-1,176,851$-32,937,592$-81,389,160$-84,650,000$-94,954,482$-92,909,968$-90,179,575$-164,215,270$-239,970,447$-31,636,185
    EBITDA$-105,852,399$-38,697,489$5.46M$-25,624,082$-73,663,212$-78,243,012$-89,409,780$-81,823,297$-85,765,189$-165,417,170$-91,025,361$6.47M
    EBIT$-111,703,499$-45,404,755$-1,023,192$-32,723,935$-81,670,137$-84,430,556$-97,141,588$-89,883,806$-93,315,230$-175,240,873$-99,993,351$-6,462,364
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CGC

    News

    Canopy Growth receives EU GMP certification

    Canopy Growth Corporation's Smiths Falls, Ontario facility has received EU Good Manufacturing Practice (GMP) certification for manufacturing and packaging activities from German authorities. This certification...

    MMJDaily•10/14/26•Bullish

    Canopy Growth Secures EU-GMP Certification for Smiths Falls Facility

    Canopy Growth Corporation has received EU-GMP certification from Germany for its Smiths Falls facility, making it Canada's only EU GMP-certified site combining softgel manufacturing with primary packaging of various...

    StratCann•10/13/26•Bullish

    Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-certified Site Combining Softgel Manufacturing with Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower - Canopy

    Canopy Growth's Smiths Falls, Ontario facility has achieved EU GMP certification for manufacturing and packaging softgels, oral liquids, and dried cannabis flower...

    Canopy Growth•10/13/26•Bullish

    Is Canopy Growth (NASDAQ:CGC) Back In Focus As Reform Talk Heats Up?

    Canopy Growth (NASDAQ:CGC) has returned to the spotlight due to renewed speculation surrounding US cannabis reform...

    Kalkine Media•10/13/26•Bullish

    Canopy Growth’s Ontario facility receives EU GMP certification

    Canopy Growth Corporation announced that its Smiths Falls facility in Ontario has received EU GMP certification for manufacturing and packaging softgels, liquids, and dried cannabis flower. This certification...

    Investing.com•10/13/26•Bullish

    CGC Valuation and Fair Value

    P/E
    -2.2x
    Forward P/E
    20.4x
    See GNG's fair value

    CGC Profitability: Margins, ROIC and FCF

    Gross margin
    24.5%
    Operating margin
    -21.7%
    Net margin
    -79.2%
    ROE
    -39.5%
    FCF margin
    -24.3%

    CGC Competitors

    CompanyTicker
    Sanara Medtech IncSMTI
    Indaptus Therapeutics IncINDP
    Arcturus Therapeutics Holdings IncARCT
    Contineum Therapeutics, Inc. Class A Common StockCTNM
    Enanta Pharmaceuticals IncENTA
    QuantumSi IncQSI
    Semler Scientific IncSMLR
    Movano IncMOVE

    Sector: Healthcare

    CGC Analyst Ratings

    Consensus
    Hold
    Analysts
    8
    Strong Buy
    0
    Buy
    2
    Hold
    6
    Sell
    0
    Strong Sell
    0

    CGC Bull Case vs Bear Case

    Bull case

    • CGC grew quarterly revenue 12.5% year over year.

    Bear case

    • CGC has a -79.2% net profit margin.
    • CGC beat EPS estimates in 25.0% of its last 8 reported quarters.

    CGC Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -174.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.03
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About CGC

    Does CGC pay dividends?

    Canopy Growth Corp (CGC) does not currently pay a regular dividend.

    What is CGC's market cap?

    Canopy Growth Corp (CGC) has a market capitalization of $321.11M with a current stock price of $0.74.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In